Cargando…

Imaging Dynamic Peroxynitrite Fluxes in Epileptic Brains with a Near‐Infrared Fluorescent Probe

Epilepsy is a chronic neurodegenerative disease, and accumulating evidence suggests its pathological progression is closely associated with peroxynitrite (ONOO(−)). However, understanding the function remains challenging due to a lack of in vivo imaging probes for ONOO(−) determination in epileptic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jiong‐sheng, Shao, Chenwen, Wang, Xueao, Di, Xiaojiao, Xue, Xuling, Su, Zhi, Zhao, Jing, Zhu, Hai‐Liang, Liu, Hong‐Ke, Qian, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685465/
https://www.ncbi.nlm.nih.gov/pubmed/31406668
http://dx.doi.org/10.1002/advs.201900341
Descripción
Sumario:Epilepsy is a chronic neurodegenerative disease, and accumulating evidence suggests its pathological progression is closely associated with peroxynitrite (ONOO(−)). However, understanding the function remains challenging due to a lack of in vivo imaging probes for ONOO(−) determination in epileptic brains. Here, the first near‐infrared imaging probe (named ONP) is presented for tracking endogenous ONOO(−) in brains of kainate‐induced epileptic seizures with high sensitivity and selectivity. Using this probe, the dynamic changes of endogenous ONOO(−) fluxes in epileptic brains are effectively monitored with excellent temporal and spatial resolution. In vivo visualization and in situ imaging of hippocampal regions clearly reveal that a higher concentration of ONOO(−) in the epileptic brains associates with severe neuronal damage and epileptogenesis; curcumin administration can eliminate excessively increased ONOO(−), further effectively protecting neuronal cells. Moreover, by combining high‐content analysis and ONP, a high‐throughput screening method for antiepileptic inhibitors is constructed, which provides a rapid imaging/screening approach for understanding epilepsy pathology and accelerating antiseizure therapeutic discovery.